MicrosoftLive sourceEvidence: Medium50/100

AI Enhances Healthcare Advertising with Microsoft and CMI Media Group Partnership

CMI Media Group partnered with Microsoft Advertising to help healthcare brands reach customers effectively amidst challenging industry dynamics like tariffs. Through Microsoft's platforms like Xbox, LinkedIn, Copilot, and AI agents, the partnership elevated media planning and targeted advertising for pharmaceutical brands.

Organization
CMI Media Group
Industry
Healthcare
Published
April 2025

Reported outcomes

Strategic outcomes

New product / capabilityDeveloped new pharma ad products and transparency toolsSpeed & agilityEnabled AI-supported planning and analysis workflowsCustomer experience & trustImproved targeted reach for healthcare brands
Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
Customer
CMI Media Group
Provider
Microsoft
Maturity
Unknown
Linked source
MediaPost

No explicit deployment-stage evidence found.

Customer identity supportedSource describes one deploymentMaturity evidence evaluated

Primary read

Use case focus

Showing 3 of 5

  • 1AI-driven media planning and optimization for pharmaceutical campaigns
  • 2Automated audience targeting using Microsoft Copilot and Xbox/LinkedIn data
  • 3AI agent support for internal analytics and decision-making
  • Rising pharmaceutical tariffs threatened industry profitability and consumer access.
  • Existing media buying focused heavily on linear TV, limiting reach to target audiences.
  • Pharmaceutical brands faced difficulty achieving ROI on ad spend amidst market pressures.
  • Traditional media measurement made it difficult to optimize and prove campaign success.
  • Agencies lacked actionable, real-time insights for planning and analysis.
  • Leveraged Microsoft Advertising’s AI-powered audience targeting across platforms like Xbox, LinkedIn, and Copilot.
  • Implemented AI agents to support internal media planning and data analysis workflows.
  • Collaborated with Microsoft to develop and test innovative ad products and transparency tools for pharma.
  • Transitioned media spend from linear TV to digital and connected TV using Microsoft’s platform analytics.
  • Enabled cost-effective, targeted reach for pharmaceutical brands despite tariff pressures.
  • Improved return on investment (ROI) for healthcare advertising clients.
  • Accelerated shift to digital channels, increasing campaign reach and efficiency.
  • Enhanced internal planner and analyst productivity through AI agent integration.
Sources & evidence1
Evidence: Medium50/100Evidence strength
  • Customer explicitly identified
  • Independent source available
  • Technical implementation details available
  • Recent evidence check available
  • Last evidence check: Jul 22, 2026.
Live sourceStill referenced

The case's original source is still reachable.

  • Cited source last checked Jun 12, 2026 — ok (0/1 broken).

Measures whether this deployment's public evidence persists — not whether the system is still in production.

Type: News ArticlePublished: Apr 8, 2025Publisher: MediaPostEvidence: SecondaryConfidence: Low

AI-generated summary. Verify important details with the linked sources before relying on this case.

Explore related AI use cases

Was this useful?

Community

Comments

Loading comments...

Similar cases